An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer

被引：0
|
作者：
H E Lee
J H Kim
Y J Kim
S Y Choi
S-W Kim
E Kang
I Y Chung
I A Kim
E J Kim
Y Choi
H S Ryu
S Y Park
机构：
[1] Seoul National University Hospital,Department of Pathology
[2] Seoul National University College of Medicine,Department of Internal Medicine
[3] Seoul National University College of Medicine,Department of Surgery
[4] Breast Care Center,Department of Radiation Oncology
[5] Seoul National University Bundang Hospital,Department of Pathology
[6] 300 Gumi-dong,Department of Pathology
[7] Bundang-gu,undefined
[8] Seongnam-si,undefined
[9] Gyeonggi 463-707,undefined
[10] Korea,undefined
[11] Seoul National University College of Medicine,undefined
[12] Seoul National University Bundang Hospital,undefined
[13] Seoul National University College of Medicine,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
breast cancer; cancer stem cells; primary systemic therapy; chemoresistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1730 / 1738
页数：8
相关论文
共 50 条
  • [1] An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
    Lee, H. E.
    Kim, J. H.
    Kim, Y. J.
    Choi, S. Y.
    Kim, S-W
    Kang, E.
    Chung, I. Y.
    Kim, I. A.
    Kim, E. J.
    Choi, Y.
    Ryu, H. S.
    Park, S. Y.
    BRITISH JOURNAL OF CANCER, 2011, 104 (11) : 1730 - 1738
  • [2] Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer
    Tokes, Timea
    Tokes, Anna-Maria
    Szentmartoni, Gyongyver
    Kiszner, Gergo
    Muhl, Dorottya
    Molnar, Bela Akos
    Kulka, Janina
    Krenacs, Tibor
    Dank, Magdolna
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (03) : 1499 - 1510
  • [3] NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells
    Zhong, Ying
    Shen, Songjie
    Zhou, Yidong
    Mao, Feng
    Lin, Yan
    Guan, Jinghong
    Xu, Yali
    Zhang, Shu
    Liu, Xu
    Sun, Qiang
    ONCOTARGETS AND THERAPY, 2016, 9 : 6885 - 6891
  • [4] Primary systemic therapy in breast cancer
    Goehring, Uwe-Jochen
    Solomayer, Erich
    BREAST CARE, 2006, 1 (04) : 234 - 237
  • [5] Primary systemic therapy of breast cancer
    Sachelarie, Irina
    Grossbard, Michael L.
    Chabha, Manjeet
    Feldman, Sheldon
    Ghesani, Munir
    Blum, Ronald H.
    ONCOLOGIST, 2006, 11 (06) : 574 - 589
  • [6] Primary systemic therapy in breast cancer - an update for gynecologic oncologists
    Szekely, B.
    Szentmartoni, G.
    Kulka, J.
    Szasz, A. M.
    Langmar, Z.
    Dank, M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2011, 32 (06) : 636 - 641
  • [7] Patterns of Regression in Breast Cancer after Primary Systemic Treatment
    Zombori, Tamas
    Cserni, Gabor
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (03) : 1153 - 1161
  • [8] Surgery after primary systemic chemotherapy in patients with breast cancer
    Eiermann, Wolfgang
    Ataseven, Beyhan
    BREAST CARE, 2006, 1 (06) : 358 - 361
  • [9] The feasibility of sentinel lymph node biopsy in breast cancer patients after primary systemic therapy
    Reitsamer, R.
    Menzel, C.
    Glueck, S.
    Schlederer, E.
    Wilhelm, C.
    Peintinger, F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S29 - S29
  • [10] Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer
    Tímea Tőkés
    Kornélia Kajáry
    Gyöngyvér Szentmártoni
    Zsolt Lengyel
    Tamás Györke
    László Torgyík
    Krisztián Somlai
    Anna-Mária Tőkés
    Janina Kulka
    Magdolna Dank
    Breast Cancer, 2017, 24 : 137 - 146
12345